Edgewell Personal Care Company EPC
Set alert
28.47 USD -0.10 -0.35%
At close · Nov 2
28.47 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
28.47 Day range 29.49
15.73 52-week range 29.95
- YTD
- +66.98%
- 1 year
- +46.83%
- Open
- 29.23
- Prev close
- 28.57
- Mkt cap
- 1.31B
- Vol
- 747.36K
- Avg vol
- 551.48K
- EPS
- -0.92
- P/E
- 0.00
- Div yield
- 2.10%
More statistics
- Low
- 28.47
- High
- 29.49
- Forward P/E
- 14.32
- Beta
- 0.40
- Short ratio
- 7.98
- Inst. own
- 121.04%
- Dividend
- 0.60
- Ex-div date
- Sep 8, 2026
- Earnings
- Nov 12, 2026
- 50-d avg
- 27.80
- 200-d avg
- 23.92
- 1y target
- 31.50
5Y chart
Events in this range
- Dec 2, 2021Dividend: 0.15
- Mar 7, 2022Dividend: 0.15
- Jun 1, 2022Dividend: 0.15
- Sep 1, 2022Dividend: 0.15
- Nov 28, 2022Dividend: 0.15
- Jan 4, 2023Dividend: 0.15
- Mar 7, 2023Dividend: 0.15
- Jun 6, 2023Dividend: 0.15
- Sep 6, 2023Dividend: 0.15
- Dec 5, 2023Dividend: 0.15
- Mar 6, 2024Dividend: 0.15
- Jun 6, 2024Dividend: 0.15
- Sep 4, 2024Dividend: 0.15
- Dec 3, 2024Dividend: 0.15
- Mar 5, 2025Dividend: 0.15
- Jun 6, 2025Dividend: 0.15
- Aug 5, 2025Earnings: 0.92; estimate 1.01; surprise -8.91%
- Sep 4, 2025Dividend: 0.15
- Nov 13, 2025Earnings: 0.68; estimate 0.82; surprise -17.07%
- Dec 4, 2025Dividend: 0.15
- Feb 9, 2026Earnings: -0.16; estimate -0.18; surprise 11.11%
- Mar 6, 2026Dividend: 0.15
- May 6, 2026Earnings: 0.6; estimate 0.43; surprise 39.53%
- Jun 10, 2026Dividend: 0.15
- Jul 16, 2026Rating: UBS · Neutral → Neutral
- Jul 21, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Aug 5, 2026Earnings: 0.72; estimate 0.645; surprise 11.63%
- Aug 6, 2026Rating: RBC Capital · Outperform → Outperform
- Aug 6, 2026Rating: UBS · Neutral → Neutral
- Aug 7, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Sep 9, 2026Dividend: 0.15
- Oct 5, 2026Rating: Wells Fargo · Overweight → Overweight
Signals (93)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| MACD: Sell Signal | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| RSI: Oversold | Dec 1, 2025 | 11 months ago |
| RSI: Oversold | Nov 17, 2025 | 11 months ago |
Newest 20 of 93.
Analyst view
Consensus: buy
Buy
Price target (mean) 31.50 +10.6% upside
Now 28.47
- Target (low)
- 29.00
- Target (mean)
- 31.50
- Target (high)
- 35.00
Ratings (0m) 7 3 buy · 4 hold · 0 sell
- Strong buy1
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.77052 | 0.758 – 0.79 | 0.68 | +13.3% | 479.80M | -10.7% | 7 |
| Next quarter | 0.01117 | -0.09 – 0.13 | -0.16 | +107.0% | 424.43M | -12.8% | 6 |
| Current year | 1.93 | 1.91 – 1.95 | 2.52 | -23.6% | 1.99B | -10.4% | 7 |
| Next year | 1.98 | 1.82 – 2.04 | 1.93 | +2.8% | 2.02B | +1.4% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 7, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 6, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 21, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 16, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 7, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 8, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 10, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 10, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jan 5, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 18, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 14, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 14, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 14, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Sep 25, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 6, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 6, 2025 | UBS | Maintained | Neutral | Neutral |
| Aug 6, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 6, 2025 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| Jul 15, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| May 8, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| May 8, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 17, 2025 | UBS | Maintained | Neutral | Neutral |
| Apr 11, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 11, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 11, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |